HopeStage
Back to all studies
CompletedNCT01263548

Lisdexamfetamine Use in Adults With ADHD and Bipolarity

About this titleRead the official source — NCT01263548
Observational studyAges 18–55Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
TorontoSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2010
Recruitment status
Completed
Enrollment listed in the registry
45
Sponsor
University Health Network, Toronto
Sponsor type
University
Study type
Observational
Intervention type
Drug
Locations
Canada
Age range
From 18 Years to 55 Years
Official registry ID
NCT01263548
Official title
Show the full official title

To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University Health Network, Toronto, a university.

Did this study involve medication?

Yes. The study involved medication, including lisdexamfetamine dimesylate.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies